Significance of FSHR and LHCGR gene polymorphisms on clinical outcomes in gonadotropin-releasing hormone antagonist protocol with freeze-all strategy: A case-control study
Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 22
This Paper With 14 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJRM-22-7_003
تاریخ نمایه سازی: 17 شهریور 1403
Abstract:
Background: Follicle-stimulating hormone receptor (FSHR) and luteinizing hormone/choriogonadotropin receptor (LHCGR) are integral to ovarian function, facilitating follicle development and maturation through their respective hormonal interactions. The influence of receptor polymorphisms on the outcomes of freeze-all cycles remains unclear.
Objective: This study investigates the impact of FSHR N۶۸۰S and LHCGR N۳۱۲S polymorphisms on clinical outcomes in freeze-all cycles.
Materials and Methods: Women undergoing controlled ovarian stimulation for assisted reproductive technology participated in this study. They were administered a gonadotropin-releasing hormone antagonist protocol, with recombinant follicle-stimulating hormone (rFSH) dosages adjusted according to age, body mass index, antral follicle count, and individual hormonal responses. Additionally, human menopausal gonadotropin dosages were tailored based on the LHCGR N۳۱۲S genetic variant.
Results: Analysis revealed no significant differences in age, body mass index, antral follicle count, or marital status across the genotypes of FSHR N۶۸۰S and LHCGR N۳۱۲S. However, notable differences were observed in the rFSH dosage required daily and in total among the FSHR polymorphism genotypes. Genotypes of the LHCGR polymorphism correlated with fewer stimulation days. A significant interaction was observed between the ۲ polymorphisms concerning total rFSH dosage.
Conclusion: The presence of serine in the FSHR polymorphism was associated with higher rFSH dosage requirements. Both FSHR N۶۸۰S and LHCGR N۳۱۲S polymorphisms significantly influenced clinical pregnancy and live birth outcomes in freeze-all cycles, underscoring the potential of a pharmacogenomic approach to optimize hormone supplementation in controlled ovarian stimulation protocols during assisted reproductive technology treatments.
Keywords:
LHCGR , FSHR , Polymorphism. , گیرنده هورمون لوتئینه کننده , گیرنده هورمون محرک فولیکول , پلی مورفیسم.
Authors
Jayesh Amin
Wings IVF Women’s Hospital, Ahmedabad, Gujarat, India.
Naga Sandhya Alle
Wings IVF Women’s Hospital, Ahmedabad, Gujarat, India.
Bansi Prajapathi
Wings IVF Women’s Hospital, Ahmedabad, Gujarat, India.
Ami patel
Wings IVF Women’s Hospital, Ahmedabad, Gujarat, India.
Pareshkumar Makwana
Wings IVF Women’s Hospital, Ahmedabad, Gujarat, India.
Jaya Prakash Gomedhikam
Life Fertility and Research Center, Collector Office Jn, Maharanipeta, Visakhapatnam, Andhra Pradesh, India.
Murali krishna Kota
Life Fertility and Research Center, Collector Office Jn, Maharanipeta, Visakhapatnam, Andhra Pradesh, India.
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :